Suzhou Basecare Medical Corporation Limited (HKG:2170)
Hong Kong
· Delayed Price · Currency is HKD 1.920
+0.020 (1.05%)
Apr 29, 2026, 2:25 PM HKT
HKG:2170 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Revenue | 233.27 | 299.11 | 207.98 | 140.9 | 107.3 | Upgrade
|
| Revenue Growth (YoY) | -22.01% | 43.82% | 47.60% | 31.32% | 32.29% | Upgrade
|
| Cost of Revenue | 109.66 | 162.89 | 116.63 | 81.37 | 56.15 | Upgrade
|
| Gross Profit | 123.61 | 136.22 | 91.35 | 59.53 | 51.15 | Upgrade
|
| Selling, General & Admin | 221.97 | 276.39 | 209.3 | 161.5 | 114.64 | Upgrade
|
| Research & Development | 106.42 | 135.26 | 129.57 | 119.77 | 73.71 | Upgrade
|
| Other Operating Expenses | -3.99 | -7.63 | -5.85 | -5.7 | -4.82 | Upgrade
|
| Operating Expenses | 324.4 | 404.01 | 333.02 | 275.57 | 183.53 | Upgrade
|
| Operating Income | -200.79 | -267.79 | -241.67 | -216.04 | -132.38 | Upgrade
|
| Interest Expense | -26.23 | -9.37 | -2.61 | -0.5 | -1.26 | Upgrade
|
| Interest & Investment Income | 11.8 | 25.27 | 38.51 | 23.62 | 18.2 | Upgrade
|
| Currency Exchange Gain (Loss) | -4.37 | 8.66 | 11.86 | 62.91 | -10.31 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.12 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -216.47 | -243.24 | -193.92 | -130.01 | -125.75 | Upgrade
|
| Gain (Loss) on Sale of Investments | -10.72 | 2.9 | -2.4 | 3.4 | - | Upgrade
|
| Pretax Income | -227.19 | -240.34 | -196.32 | -126.61 | -125.75 | Upgrade
|
| Income Tax Expense | -3.74 | -3.13 | -2.97 | 6.01 | 18.33 | Upgrade
|
| Earnings From Continuing Operations | -223.46 | -237.21 | -193.35 | -132.63 | -144.08 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 9.12 | - | Upgrade
|
| Net Income to Company | -223.46 | -237.21 | -193.35 | -123.51 | -144.08 | Upgrade
|
| Minority Interest in Earnings | - | 0.18 | 1.66 | 0.84 | 0.43 | Upgrade
|
| Net Income | -223.46 | -237.03 | -191.69 | -122.66 | -143.65 | Upgrade
|
| Net Income to Common | -223.46 | -237.03 | -191.69 | -122.66 | -143.65 | Upgrade
|
| Shares Outstanding (Basic) | 274 | 274 | 274 | 274 | 265 | Upgrade
|
| Shares Outstanding (Diluted) | 274 | 274 | 274 | 274 | 265 | Upgrade
|
| Shares Change (YoY) | - | - | - | 3.09% | 54.34% | Upgrade
|
| EPS (Basic) | -0.82 | -0.87 | -0.70 | -0.45 | -0.54 | Upgrade
|
| EPS (Diluted) | -0.82 | -0.87 | -0.70 | -0.45 | -0.54 | Upgrade
|
| Free Cash Flow | - | -322.41 | -371.44 | -317.22 | -226.75 | Upgrade
|
| Free Cash Flow Per Share | - | -1.18 | -1.36 | -1.16 | -0.85 | Upgrade
|
| Gross Margin | 52.99% | 45.54% | 43.92% | 42.25% | 47.67% | Upgrade
|
| Operating Margin | -86.08% | -89.53% | -116.20% | -153.33% | -123.38% | Upgrade
|
| Profit Margin | -95.79% | -79.25% | -92.17% | -87.06% | -133.88% | Upgrade
|
| Free Cash Flow Margin | - | -107.79% | -178.60% | -225.14% | -211.33% | Upgrade
|
| EBITDA | -170.6 | -237.6 | -227.18 | -210.59 | -129.5 | Upgrade
|
| EBITDA Margin | -73.13% | -79.44% | -109.23% | -149.46% | -120.69% | Upgrade
|
| D&A For EBITDA | 30.19 | 30.19 | 14.49 | 5.45 | 2.89 | Upgrade
|
| EBIT | -200.79 | -267.79 | -241.67 | -216.04 | -132.38 | Upgrade
|
| EBIT Margin | -86.08% | -89.53% | -116.20% | -153.33% | -123.38% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.